百奥赛图-B(02315)：共轻链小鼠RenLite®技术平台获得美国专利授权

智通财经06-21

智通财经APP讯，百奥赛图-B(02315)发布公告，该公司自主研发的全人共轻链小鼠RenLite®技术平台获得美国专利及商标局(United States Patent and Trademark Office)专利授权。RenLite小鼠是百奥赛图利用自主研发的超大片段染色体工程技术-SUPCE(size-unlimited precise chromosome engineering)制备...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2445733961?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-06-21 16:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2445733961","market":"hk","top_or_hot":-1,"title":"百奥赛图-B(02315)：共轻链小鼠RenLite®技术平台获得美国专利授权","media":"智通财经","content":"<div>\n<p>智通财经APP讯，百奥赛图-B(02315)发布公告，该公司自主研发的全人共轻链小鼠RenLite®技术平台获得美国专利及商标局(United States Patent and Trademark Office)专利授权。RenLite小鼠是百奥赛图利用自主研发的超大片段染色体工程技术-SUPCE(size-unlimited precise chromosome engineering)制备...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1138562.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>百奥赛图-B(02315)：共轻链小鼠RenLite®技术平台获得美国专利授权</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n百奥赛图-B(02315)：共轻链小鼠RenLite®技术平台获得美国专利授权\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-21 16:34 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1138562.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，百奥赛图-B(02315)发布公告，该公司自主研发的全人共轻链小鼠RenLite®技术平台获得美国专利及商标局(United States Patent and Trademark Office)专利授权。RenLite小鼠是百奥赛图利用自主研发的超大片段染色体工程技术-SUPCE(size-unlimited precise chromosome engineering)制备...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1138562.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1138562.html","article_id":"2445733961","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2445733961","pubTimestamp":1718958842,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，百奥赛图-B 发布公告，该公司自主研发的全人共轻链小鼠RenLite技术平台获得美国专利及商标局专利授权。此前，RenLite技术平台已在中国、美国、欧洲、日本、韩国、加拿大、新加坡、俄罗斯、以色列、澳大利亚等地递交专利申请，相关专利授权在陆续推进中。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1161":"生物科技","02315":"百奥赛图-B"},"translate_title":"Biocytogen-B (02315): Co-light chain mouse RenLite ® technology platform obtained US patent authorization","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02315":1},"content_text":"智通财经APP讯，百奥赛图-B(02315)发布公告，该公司自主研发的全人共轻链小鼠RenLite®技术平台获得美国专利及商标局(United States Patent and Trademark Office)专利授权。RenLite小鼠是百奥赛图利用自主研发的超大片段染色体工程技术-SUPCE(size-unlimited precise chromosome engineering)制备而成，具有完整的人抗体重链可变区基因和固定的人抗体轻链可变区基因，可产生具有共同轻链的全人抗体，在双抗组装时能够有效避免轻重链错配，显著降低CMC工艺开发难度;这些抗体具有丰富的多样性，组成的双抗分子结构与单抗类似，显示出良好的理化性质。百奥赛图已基于RenLite及RenLite KO小鼠生成针对200+TAA靶点的抗体库，可快速应用于双抗及双抗ADC等药物的开发。除RenLite技术平台外，百奥赛图自主研发RenMice®系列平台还包括RenMab®、 RenNano®、RenTCRTM、RenTCR-mimicTM共五大全人抗体/TCR小鼠，满足全球药企的多元化药物研发需求。RenMice系列小鼠自2019年陆续发布以来得到了全球生物医药领域的广泛认可和支持。截至2023年12月31日，百奥赛图已与包括多家MNC在内的20多家生物制药/生物技术公司达成47个靶点项目的RenMice 平台授权合作，包括德国默克、杨森、美国Xencor、百济神州、信达生物等;由 RenMice平台产生的针对上千靶点的40多万条全人抗体分子库及高质量候选抗体分子，已实现103项药物合作开发及授权/转让合作。此次RenLite平台关键技术的专利授权充分体现了百奥赛图的技术创新实力和国际竞争力，公司也将持续开展全球专利布局和关键技术保护，为合作伙伴提供先进的技术平台和重要的知识产权保障。此前，RenLite技术平台已在中国、美国、欧洲、日本、韩国、加拿大、新加坡、俄罗斯、以色列、澳大利亚等地递交专利申请，相关专利授权在陆续推进中。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2445733961"}